Association between transitory increase in PTH following denosumab administration and reduced intracortical porosity is a distinctive attribute of denosumab therapy
E. Seeman, C. Libanati, M. Austin, R. Chapurlat⁎, S. Boyd, R. Zebaze, D. Hanley, J. Zanchetta, A. Grauer, J. BilezikianVolume:
50
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.bone.2012.02.507
File:
PDF, 130 KB
english, 2012